Trials / Completed
CompletedNCT04739748
Prognostic Biomarkers in Predicting Mortality in Respiratory Patients With Ventilator-Associated Pneumonia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 136 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate prognostic efficiency RDW and NLR for mortality prediction in respiratory patients with VAP.
Detailed description
Ventilator-associated pneumonia (VAP) is the most common nosocomial infection. VAP continues to be a leading cause of morbidity and mortality in the nosocomial setting. Red cell distribution width (RDW) and neutrophil-lymphocyte ratio (NLR) are prognostic factors to mortality in different diseases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | complete blood picture | Measure the red blood cell distribution width (RDW), the neutrophil-lymphocyte ratio (NLR). |
Timeline
- Start date
- 2018-04-06
- Primary completion
- 2019-12-07
- Completion
- 2019-12-07
- First posted
- 2021-02-05
- Last updated
- 2021-02-08
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04739748. Inclusion in this directory is not an endorsement.